SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000920465-19-000032
Filing Date
2019-02-13
Accepted
2019-02-13 18:25:24
Documents
1
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 wf-form5_155010030902407.html 5  
1 FORM 5 wf-form5_155010030902407.xml 5 9363
  Complete submission text file 0000920465-19-000032.txt   10608
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address
TIDMARSH GEORGE F (Reporting) CIK: 0001287235 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-36282 | Film No.: 19599456